219 related articles for article (PubMed ID: 6193296)
1. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
2. [Antineoplastic drug-induced pneumonitis-fibrosis].
Oizumi K; Nakai Y; Konno K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
[TBL] [Abstract][Full Text] [Related]
3. Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung.
Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shibuya M; Shimabukuro Z; Niitani H; Hoshi A
Cancer Treat Rep; 1983 Apr; 67(4):385-7. PubMed ID: 6189601
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy with peplomycin and carboquone (esquinon) for squamous cell carcinoma of the lung].
Negoro S; Fukuoka M; Takada M; Tamai S; Sakai N; Matsui K
Gan To Kagaku Ryoho; 1982 Mar; 9(3):522-8. PubMed ID: 6191699
[TBL] [Abstract][Full Text] [Related]
5. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.
Sikic BI; Siddik ZH; Gram TE
Cancer Treat Rep; 1980; 64(4-5):659-67. PubMed ID: 6159079
[TBL] [Abstract][Full Text] [Related]
6. [Influence of peplomycin on pulmonary function (PaO2, %DLco) in patients with oral carcinoma].
Yamamoto T; Satake H; Ueta E; Kimura T; Doi S; Osaki T
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1251-6. PubMed ID: 11579635
[TBL] [Abstract][Full Text] [Related]
7. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
[TBL] [Abstract][Full Text] [Related]
8. Effect of pepleomycin in prostatic cancer. A preliminary report.
Niijima T; Koiso K
Scand J Urol Nephrol Suppl; 1980; 55():177-9. PubMed ID: 6163206
[TBL] [Abstract][Full Text] [Related]
9. [Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma].
Kanazawa H; Takahashi K; Hanazawa Y; Uchiyama S; Takahara T; Takahara M; Muto M; Kinehara M; Sato K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):775-80. PubMed ID: 2469396
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary fibrogenetic activities of pepleomycin].
Kiuchi H
Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Sep; 21(9):823-8. PubMed ID: 6202914
[No Abstract] [Full Text] [Related]
11. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experiences with pepleomycin].
Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
[TBL] [Abstract][Full Text] [Related]
13. [Probable pulmonary damage caused by bleomycin. Communication of 4 cases].
Arraztoa J; Oddó D; Cerda B; San Martin S
Rev Med Chil; 1991 Nov; 119(11):1270-6. PubMed ID: 9723079
[TBL] [Abstract][Full Text] [Related]
14. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effects and pulmonary toxicity of bleomycin administered by continuous subcutaneous infusion in patients with advanced cervical cancer].
Miyamoto T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1830-5. PubMed ID: 2439018
[TBL] [Abstract][Full Text] [Related]
16. [Effects of pepleomycin (PEP) infused through bronchial artery for lung cancer: in comparison with the cases of mitomycin (MMC) or carboquon (CQ)].
Yokoyama K; Kaito S; Sobajima T; Fukumoto H; Horiguchi Y; Takeuchi A; Kurokawa A
Gan To Kagaku Ryoho; 1982 Apr; 9(4):688-93. PubMed ID: 6191702
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
19. Pepleomycin-induced pneumonitis resulting in death.
Watanabe I; Yokobayashi T; Nakajima T; Mizutani H; Ohashi Y
J Maxillofac Surg; 1984 Jun; 12(3):114-7. PubMed ID: 6205113
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
